Ayrshire Central Hospital, also known as Irvine Central Hospital, is an NHS hospital in Irvine, North Ayrshire, Scotland. It is managed by NHS Ayrshire and Arran.
Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is increasingly utilized for hemorrhage control in trauma; however, zone-specific outcomes in abdominal trauma remain inadequately characterized. We retrospectively analyzed 404 patients with abdominal trauma who underwent REBOA between 2019 and 2022. Patients were stratified by aortic occlusion zone (zones 1, 2, or 3), and their demographic characteristics, injury patterns, resuscitation requirements, and clinical outcomes were compared. The cohort was predominantly male (83.8
Early diagnosis and treatment of immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICIs) are essential because they directly impact patient quality of life. This report describes the case of an 85-year-old woman with type 2 diabetes on insulin therapy, whose glycemic fluctuations became highly unstable following irAE development. During treatment for refractory hepatocellular carcinoma with tremelimumab and durvalumab, she developed hyperglycemia and was hospitalized. Endogenous insulin secretion remained intact, and hyperglycemia improved after admission. Continuous glucose monitoring (CGM) revealed nocturnal and early-morning hypoglycemia from the fourth day of admission. Insulin requirements were tapered off; however, persistent anorexia and dyspnea led to the diagnosis of hypopituitarism through endocrine testing. For patients with diabetes who experience abnormal blood glucose fluctuations after ICI therapy, clinicians should monitor changes in endogenous insulin secretion and consider the possibility of hypoadrenocorticism. CGM may be valuable for detecting these endocrine abnormalities.
The treatment landscape for multiple sclerosis has changed significantly over recent years. Independent nurse prescribing has become an important component of many multiple sclerosis services, supporting access to therapies, medication review and long-term disease management. The updated National Institute for Health and Care Excellence guideline on multiple sclerosis in adults (NG220) provides an opportunity to consider the contribution of nurse prescribers to evidence-based practice. This article examines the implications of NG220 for nurse prescribers, with focus on multiple sclerosis medicines optimisation, symptom management, relapse treatment, disease-modifying therapies monitoring and shared decision making. It explores ongoing challenges relating to clinical governance, workforce capacity and variation in access to treatments across the UK, and argues that nurse prescribers play an important role in supporting implementation of national recommendations while contributing to safe, effective and person-centred care.
Port-wine stain (PWS) is a congenital vascular malformation commonly treated with pulsed dye laser (PDL) therapy. PDL exploits selective photothermolysis, in which hemoglobin in red blood cells (RBCs) absorbs laser energy, generating localized heat that induces endothelial damage. However, in microvessels, axial RBC migration creates a hemoglobin-depleted cell-free layer along the vessel walls, reducing laser efficacy. Hemoglobin vesicles (HbVs)—nano-sized artificial RBCs—distribute uniformly within these layers, offering the potential to enhance hemoglobin distribution and laser absorption. To investigate the impact of HbV administration on PDL therapy, a three-dimensional numerical model of human skin tissue containing vascular networks was developed. Monte Carlo simulations were used to evaluate laser absorption, and thermal conduction analysis was performed to compute temperature distributions and estimate thermal damage via the Arrhenius model. Two conditions were considered: Case 1 (without HbV administration) and Case 2 (with HbV administration). In Case 2, HbV administration increased optical absorption in vessel walls and enhanced thermal damage, particularly in subpapillary vessels. The threshold energy fluence required to induce irreversible thermal damage was reduced, and heat flux at the upper vessel walls was elevated. These findings indicate that HbV administration enhances the homogeneity and efficacy of PDL-induced vascular damage, potentially allowing effective treatment at lower energy fluences while minimizing off-target tissue injury. The study provides a theoretical basis for optimizing PDL parameters in PWS therapy and underscores the potential of patient-specific treatment protocols using artificial blood substitutes.
INTRODUCTION:Exercise may slow Multiple Sclerosis (MS) progression and is considered safe for all people with MS. A review of exercise for those with severe MS was published in 2017, with guidelines for physical activity and exercise updated in 2020. The evidence base has subsequently increased, warranting further review. OBJECTIVE:To investigate the effectiveness of exercise interventions on physiological fitness, physical and cognitive function, common symptoms, and disease impact in people with severe MS. METHODS:A search was conducted across five electronic databases. Randomised control trials applying an exercise intervention to participants diagnosed with MS, EDSS 6.5-8.0, with outcome measures of physiological fitness, physical function, cognitive function, spasticity, fatigue, or disease impact were included. RESULTS:In total 29 studies published in 31 articles were included, with 1181 participants. Only six studies included participants exclusively with an EDSS ≥6.5. Studies predominantly reported outcome measures of physiological fitness (n = 16), physical function (n = 25), and MS symptoms and disease impact (n = 25), with the majority finding an improvement in at least one outcome measure. Comparatively few studies reported outcome measures of upper limb function (n = 4) and cognitive performance (n = 3). CONCLUSIONS:Exercise appears to improve physiological fitness, physical function, and disease impact, but not disability status. These improvements largely occurred in studies which included participants at an EDSS <6.5. Improvements were limited in studies which exclusively recruited participants at an EDSS ≥6.5. Further research is required to establish the specific effects for those severely affected by MS, especially those who are non-ambulatory.